4//SEC Filing
English Emily 4
Accession 0001453687-25-000089
CIK 0001453687other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:15 PM ET
Size
7.2 KB
Accession
0001453687-25-000089
Insider Transaction Report
Form 4
English Emily
Chief Operations Officer
Transactions
- Exercise/Conversion
Common Stock
2025-05-12$3.30/sh+7,500$24,750→ 55,226 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-12−7,500→ 34,369 totalExercise: $3.30Exp: 2031-04-25→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]These options are currently fully vested and exercisable.
- [F2]On November 13, 2023, the issuer acquired the Delaware corporation which was then-known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the issuer's common stock in connection with the merger.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0002019791
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:15 PM ET
- Size
- 7.2 KB